← Back to Analyst Consensus 
QNRX Buy
Quoin Pharmaceuticals Ltd.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 2 upgrades / ▼ 0 downgrades / 0 reiterations from 2 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | Canaccord Genuity | initiate | — → Buy | $18 | 48% |
| Oct 12, 2026 | BTIG | initiate | — → Buy | $14 | 52% |
| Sep 23, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| May 4, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 32% |
| Mar 15, 2024 | Maxim Group | maintain | Buy → Buy | $4 | 42% |
Price Target Trend
Mar 31, 2026 Latest: $20.38 Oct 25, 2026
EPS Estimates
+1q $-1.81
Lo: $-2.18 Hi: $-1.44
2 analysts 0y $-7.17
Lo: $-7.89 Hi: $-6.45
2 analysts ▲1
+1y $-3.19
Lo: $-4.45 Hi: $-1.92
2 analysts 0q $-1.76
Lo: $-2.05 Hi: $-1.47
2 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days